Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

When Will Moderna Stock Be a Screaming Buy?


Moderna (NASDAQ: MRNA) is now far below its peak market cap last summer of nearly $200 billion. But when will the vaccine stock be a screaming buy for investors? In this Motley Fool Live video recorded on Jan. 5, Fool contributors Keith Speights and Brian Orelli discuss how low Moderna needs to go to make the stock a clear bargain.

Continue reading


Source Fool.com

Like: 0
Share

Comments